Progress in understanding the structure–activity relationships of P-glycoprotein
- 1 March 2002
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 54 (3), 315-328
- https://doi.org/10.1016/s0169-409x(02)00006-6
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Multidrug resistance (MDR) in cancerEuropean Journal of Pharmaceutical Sciences, 2000
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- P-Glycoprotein, a gatekeeper in the blood–brain barrierAdvanced Drug Delivery Reviews, 1999
- In VivoModel Systems in P-Glycoprotein-Mediated Multidrug ResistanceCritical Reviews in Clinical Laboratory Sciences, 1998
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 1994
- P‐glycoprotein transports corticosterone and is photoaffinity‐labeled by the steroidInternational Journal of Cancer, 1992
- Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.Journal of Histochemistry & Cytochemistry, 1989
- Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.Proceedings of the National Academy of Sciences, 1989
- Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proceedings of the National Academy of Sciences, 1987